{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:40:48Z","timestamp":1790862048332,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijantimicag.2011.04.022","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T12:12:32Z","timestamp":1310040752000},"page":"291-295","source":"Crossref","is-referenced-by-count":43,"title":["Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009"],"prefix":"10.1016","volume":"38","author":[{"given":"Ronald N.","family":"Master","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Bordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.109.4.1019","article-title":"Ventilator-associated pneumonia due to Pseudomonas aeruginosa","volume":"109","author":"Brewer","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1592\/phco.28.2.235","article-title":"The current state of multidrug-resistant Gram-negative bacilli in North America","volume":"28","author":"Nicasio","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/dkg102","article-title":"Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections","volume":"51","author":"Van Eldere","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0020","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","article-title":"National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002","volume":"48","author":"Obritsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.04.022_bib0025","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1086\/426188","article-title":"Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001\u20132003 Tracking Resistance in the United States Today surveillance studies","volume":"40","author":"Karlowsky","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0030","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0035","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"2587","article-title":"Pseudomonas aeruginosa","author":"Pier","year":"2005"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0040","unstructured":"Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline. 3rd ed. Document M39-A3. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diagmicrobio.2009.08.020","article-title":"Summary trends for the Meropenem Yearly Susceptibility Test Information Collection program: a 10-year experience in the United States (1999\u20132008)","volume":"65","author":"Rhomberg","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/520195","article-title":"Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database\u2014USA","volume":"29","author":"Sahm","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0055","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0060","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/AAC.47.5.1681-1688.2003","article-title":"Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/528712","article-title":"Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint","volume":"46","author":"Tam","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.022_bib0070","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"\u03b2 Lactam monotherapy versus \u03b2 lactam\u2013aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T16:51:50Z","timestamp":1543683110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911002354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0924857911002354"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.04.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}